Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Commercial Officer

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for r...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-01	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-04-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-01	Premium	bought	Premium	Premium	Premium	-
2024-01-29	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-29	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-26	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-21	Premium	bought	Premium	Premium	Premium	-
2023-10-16	Premium	bought	Premium	Premium	Premium	-
2022-12-19	Premium	bought	Premium	Premium	Premium	-
2021-12-28	Premium	gifted	Premium	Premium	Premium	Chief Commercial Officer
2021-11-19	Premium	bought	Premium	Premium	Premium	Chief Commercial Officer
2021-09-20	Premium	acquired	Premium	Premium	Premium	-
2021-09-20	Premium	sold	Premium	Premium	Premium	-

ATXS - Astria Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ATXS